NCT01125449 2025-05-18
Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease
Situs Cancer Research Center
Phase 2 Withdrawn
Situs Cancer Research Center
Peking University
University Health Network, Toronto
University of Michigan Rogel Cancer Center
Jules Bordet Institute